BIND Therapeutics, Inc.

What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Tom Mathies | Send Message 21 Dec 2015

    Watch For BIND Prostate Cancer Data In Early January, 2016 $BIND
      • HAVIN_FUN | Send Message 14 Dec 2015

        $BIND Management needs to do some damage control
          • HAVIN_FUN | Send Message 14 Dec 2015

            $BIND why is bind being sold off???
            Reply (2)
            • User 14311692 | Send Message 14 Dec 2015
              : $BIND announced: phase 2 iNSITE 1 trial will advance to the second stage; the KRAS mutant NSCLC arm will not advance to the second stage.
            • User 14311692 | Send Message 14 Dec 2015
              : so it's being sold off for the latter half of my previous statement.
              • timtrading | Send Message 9 Oct 2015

                bullish engulfing scan $AGN,$HRB,$EJ,$AMRN,$SERV,$NGG,$TDOC,$BIND
                  • I_JUNGLE_BOY | Send Message 27 Jul 2015

                    bought $BIND 2day @ the potential upside
                    Reply (1)
                    • DWD Investing | Send Message 7 Dec 2015
                      : Sorry for your current loss. Down on nothing.
                      • I_JUNGLE_BOY | Send Message 23 Jun 2015

                        $BIND now has two Accurins in clinical development.
                          • Roy Manning III | Send Message 26 May 2015

                            $BIND up nicely today. Look for continued action as $AZ starts live trials of its accurrin drug. $BIND will keep recruiting for its trials.
                              • a.hofmann | Send Message 7 May 2015

                                Great Q1 earnings by $BIND
                                Reply (3)
                              • View all 3 replies
                                • a.hofmann | Send Message 8 May 2015
                                  : I'll admit I'm sort of an idiot, i was just pleased they beat the estimates on both top and bottom line. Cheers
                                • Jeffrey Sovis | Send Message 11 May 2015
                                  : Well I think you figured out a good pick
                                  • Jeffrey Sovis | Send Message 27 Apr 2015

                                    Good day to pick up some $BIND
                                      • Jeffrey Sovis | Send Message 13 Apr 2015

                                        $BIND, how this thing got so beaten I do not know, preclinical data is solid proof, it works, the study is small but high level quality
                                        Reply (1)
                                        • T-time | Send Message 14 Apr 2015
                                          : yeah but on its way back up since the low few weeks ago - time to buy!
                                          Company Description
                                          Bind Therapeutics Inc is a clinical-stage nanomedicine platform company developing a pipeline of Accurins, its novel targeted therapeutics designed to result in superior patient outcomes by increasing the concentration & duration of therapeutic payloads.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States